An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell‐Mediated Anti‐Tumor Immunity
An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell‐Mediated Anti‐Tumor Immunity
Lu Cui, Xiaojun Xia, L Wang, Haitao Zhang et al.
Journal
Small
Topics
Immunotherapy and Immune Responses
article
An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell‐Mediated Anti‐Tumor Immunity
Lu Cui, Xiaojun Xia, L Wang, Haitao Zhang, Zining Wang, C. Xie, Huan Jin, Li Li, Chunlei Dai, Huanling Zhang, Z Z Wu, Guo H, Yuxin Lin, Ruhui Yao, J J Xue, Jiahong Yi, Zixuan Guo, Jiaxin Wu, Jun Wu, Xinru You, Yue Zhao, Tiantian Wang
article en
Abstract
No abstract available for this paper.
Publication Tag
Small
Institutions
Brigham and Women's Hospital (US), Sun Yat-sen University (CN), First Affiliated Hospital of Jiangxi Medical College (CN), Key Laboratory of Guangdong Province (CN), Sun Yat-sen University Cancer Center (CN), Southern Medical University (CN), Hainan Medical University (CN), University of Hong Kong (HK), South China University of Technology (CN)
Funders
National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province